ELIZABETH VICKERS: Open Payments
NPI 1760979041 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,051 in 81 payments from 22 companies in 2025. Trend: 2023 $2,947 · 2024 $1,032 · 2025 $2,051
Food & beverage: $2,051
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 16 | $393 |
| Ferring Pharmaceuticals Inc. | 9 | $310 |
| Medtronic, Inc. | 9 | $257 |
| UROGEN PHARMA, INC. | 6 | $164 |
| ACCORD HEALTHCARE, INC. | 5 | $115 |
| TOLMAR, INC. | 4 | $107 |
| Endo USA, Inc. | 4 | $102 |
| ABBVIE INC. | 5 | $101 |
| Novartis Pharmaceuticals Corporation | 3 | $72 |
| PFIZER INC. | 3 | $63 |
Products named: GEMTESA, ADSTILADRIN, INTERSTIM, JELMYTO, Xtandi, Camcevi, ELIGARD, XIAFLEX.
Industry payments across KY — which companies pay providers there.
